WGS
GeneDx Holdings Corp. NASDAQ Listed Nov 4, 2020$40.50
Mkt Cap $1.2B
52w Low $32.21
6.0% of range
52w High $170.87
50d MA $69.18
200d MA $108.57
P/E (TTM)
-89.6x
EV/EBITDA
534.9x
P/B
5.7x
Debt/Equity
0.5x
ROE
-6.8%
P/FCF
245.2x
RSI (14)
—
ATR (14)
—
Beta
2.19
50d MA
$69.18
200d MA
$108.57
Avg Volume
742.2K
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
North Tower · Stamford, CT 06902 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | AMC | -0.06 | -0.28 | -366.7% | 67.93 | -45.6% | -49.2% | -48.9% | -40.4% | — | — | — |
| Feb 23, 2026 | AMC | 0.11 | 0.14 | +27.3% | 87.08 | -3.5% | -7.3% | -9.4% | -6.5% | -8.5% | -14.8% | — |
| Oct 28, 2025 | AMC | 0.28 | 0.49 | +75.0% | 137.47 | -0.7% | -4.2% | -4.3% | -0.4% | +0.6% | +1.5% | — |
| Jul 29, 2025 | AMC | 0.10 | 0.50 | +400.0% | 91.78 | +3.0% | +12.8% | +11.1% | +10.7% | +18.1% | +16.2% | — |
| Apr 30, 2025 | AMC | 0.11 | 0.28 | +154.5% | 66.85 | +6.7% | -6.8% | +0.6% | -1.0% | -5.4% | -14.2% | — |
| Feb 18, 2025 | AMC | 0.04 | 0.70 | +1650.0% | 112.76 | +0.2% | -1.3% | -9.9% | -15.0% | -15.8% | -15.0% | — |
| Oct 29, 2024 | AMC | -0.19 | 0.04 | +121.1% | 84.02 | +0.2% | -1.0% | -2.8% | -7.5% | -10.5% | -10.9% | — |
| Jul 30, 2024 | AMC | -0.26 | -0.11 | +57.7% | 30.13 | +16.2% | +8.6% | +7.0% | -0.2% | -6.4% | -4.3% | — |
| Apr 29, 2024 | AMC | -0.68 | -0.33 | +51.5% | 11.00 | +29.8% | +55.2% | +90.2% | +77.3% | +78.7% | +77.5% | — |
| Feb 20, 2024 | AMC | -0.60 | -0.59 | +1.7% | 5.24 | -5.7% | +32.6% | +56.7% | +50.4% | +55.2% | +53.8% | — |
| Oct 30, 2023 | AMC | -1.18 | -0.82 | +30.5% | 2.67 | -18.0% | -30.3% | -29.6% | -31.1% | -31.8% | -38.6% | — |
| Aug 8, 2023 | AMC | -1.47 | -1.65 | -12.2% | 6.65 | -2.1% | -12.6% | -20.0% | -20.8% | -21.5% | -22.9% | — |
| May 9, 2023 | AMC | -1.65 | -2.82 | -70.9% | 8.35 | -1.2% | -2.4% | -11.0% | -17.5% | -14.0% | -24.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 20 | Canaccord Genuity | Maintains | Buy → Buy | — | $65.96 | $65.96 | +0.0% | +5.7% | +3.2% | +5.9% | +0.4% | +3.9% |
| Mar 30 | Guggenheim | Maintains | Buy → Buy | — | $57.09 | $57.09 | +0.0% | +4.4% | +12.5% | +14.8% | +16.0% | +16.7% |
| Feb 24 | Piper Sandler | Maintains | Overweight → Overweight | — | $87.08 | $84.02 | -3.5% | -7.3% | -9.4% | -6.5% | -8.5% | -14.8% |
| Feb 24 | BTIG | Maintains | Buy → Buy | — | $87.08 | $84.02 | -3.5% | -7.3% | -9.4% | -6.5% | -8.5% | -14.8% |
| Feb 9 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $84.29 | $89.54 | +6.2% | +8.2% | +12.4% | +8.5% | +7.6% | +7.0% |
| Dec 22 | Canaccord Genuity | Maintains | Buy → Buy | — | $140.44 | $142.00 | +1.1% | -0.2% | -3.6% | -3.1% | -4.7% | -7.9% |
| Dec 15 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $151.51 | $151.74 | +0.2% | -0.6% | -6.5% | -10.3% | -10.0% | -7.3% |
| Dec 12 | BTIG | Maintains | Buy → Buy | — | $155.37 | $157.15 | +1.1% | -2.5% | -3.1% | -8.8% | -12.5% | -12.3% |
| Nov 4 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $138.30 | $134.91 | -2.5% | +0.9% | -1.0% | +0.3% | +1.0% | +3.1% |
| Oct 29 | BTIG | Maintains | Buy → Buy | — | $137.47 | $136.54 | -0.7% | -4.2% | -4.3% | -0.4% | +0.6% | +1.5% |
| Oct 29 | Canaccord Genuity | Maintains | Buy → Buy | — | $137.47 | $136.54 | -0.7% | -4.2% | -4.3% | -0.4% | +0.6% | +1.5% |
| Oct 29 | Guggenheim | Maintains | Buy → Buy | — | $137.47 | $136.54 | -0.7% | -4.2% | -4.3% | -0.4% | +0.6% | +1.5% |
| Oct 22 | BTIG | Maintains | Buy → Buy | — | $121.77 | $122.49 | +0.6% | -0.6% | +2.7% | +5.8% | +7.3% | +12.9% |
| Sep 11 | Piper Sandler | Maintains | Overweight → Overweight | — | $123.20 | $126.83 | +2.9% | +2.2% | +0.6% | -0.9% | -1.5% | +3.8% |
| Aug 4 | Piper Sandler | Maintains | Overweight → Overweight | — | $101.60 | $103.03 | +1.4% | +6.6% | +5.0% | +4.2% | +4.3% | +3.5% |
| Jul 30 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $91.78 | $94.54 | +3.0% | +12.8% | +11.1% | +10.7% | +18.1% | +16.2% |
| Jun 30 | Guggenheim | Maintains | Buy → Buy | — | $91.10 | $93.17 | +2.3% | +1.3% | -0.9% | -1.4% | +0.6% | -5.9% |
| May 9 | Jefferies | Upgrade | Hold → Buy | — | $56.36 | $59.00 | +4.7% | +4.9% | +4.7% | +8.1% | +5.5% | +12.9% |
| May 1 | TD Securities | Maintains | Buy → Buy | — | $66.85 | $71.36 | +6.7% | -6.8% | +0.6% | -1.0% | -5.4% | -14.2% |
| May 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $66.85 | $71.36 | +6.7% | -6.8% | +0.6% | -1.0% | -5.4% | -14.2% |
| Feb 19 | Goldman Sachs | Maintains | Neutral → Neutral | — | $112.76 | $112.94 | +0.2% | -1.3% | -9.9% | -15.0% | -15.8% | -15.0% |
| Jan 7 | TD Cowen | Maintains | Buy → Buy | — | $89.61 | $94.18 | +5.1% | +8.3% | +7.8% | -0.3% | -5.1% | -19.6% |
| Oct 30 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $84.02 | $84.20 | +0.2% | -1.0% | -2.8% | -7.5% | -10.5% | -10.9% |
| Oct 30 | Craig-Hallum | Maintains | Buy → Buy | — | $84.02 | $84.20 | +0.2% | -1.0% | -2.8% | -7.5% | -10.5% | -10.9% |
| Oct 30 | Goldman Sachs | Maintains | Neutral → Neutral | — | $84.02 | $84.20 | +0.2% | -1.0% | -2.8% | -7.5% | -10.5% | -10.9% |
| Oct 24 | Craig-Hallum | Maintains | Buy → Buy | — | $56.08 | $57.18 | +2.0% | +5.4% | +4.9% | -0.0% | +49.8% | +48.4% |
| Oct 16 | Goldman Sachs | Maintains | Neutral → Neutral | — | $59.99 | $60.50 | +0.9% | +1.3% | -6.7% | +0.1% | -3.0% | -3.7% |
| Jul 31 | TD Cowen | Maintains | Buy → Buy | — | $30.13 | $35.00 | +16.2% | +8.6% | +7.0% | -0.2% | -6.4% | -4.3% |
| Jul 31 | Goldman Sachs | Maintains | Neutral → Neutral | — | $30.13 | $35.00 | +16.2% | +8.6% | +7.0% | -0.2% | -6.4% | -4.3% |
| Jul 31 | Craig-Hallum | Maintains | Buy → Buy | — | $30.13 | $35.00 | +16.2% | +8.6% | +7.0% | -0.2% | -6.4% | -4.3% |
| Jul 31 | BTIG | Maintains | Buy → Buy | — | $30.13 | $35.00 | +16.2% | +8.6% | +7.0% | -0.2% | -6.4% | -4.3% |
| Jul 17 | Goldman Sachs | Maintains | Neutral → Neutral | — | $32.06 | $31.31 | -2.3% | +3.9% | +1.7% | -0.7% | +1.4% | +3.8% |
| Jun 26 | BTIG | Maintains | Buy → Buy | — | $27.25 | $28.25 | +3.7% | -3.9% | -2.2% | -4.1% | +5.3% | +1.9% |
| Apr 30 | TD Cowen | Maintains | Buy → Buy | — | $11.00 | $14.28 | +29.8% | +55.2% | +90.2% | +77.3% | +78.7% | +77.5% |
| Apr 30 | BTIG | Maintains | Buy → Buy | — | $11.00 | $14.28 | +29.8% | +55.2% | +90.2% | +77.3% | +78.7% | +77.5% |
| Apr 22 | BTIG | Maintains | Buy → Buy | — | $9.64 | $9.86 | +2.3% | +7.8% | +24.5% | +22.6% | +15.9% | +14.9% |
| Apr 15 | Goldman Sachs | Maintains | Neutral → Neutral | — | $9.62 | $9.78 | +1.7% | +2.7% | -0.1% | -4.4% | -0.5% | +0.2% |
| Nov 1 | Goldman Sachs | Maintains | Neutral → Neutral | — | $1.86 | $1.83 | -1.6% | +1.1% | -1.1% | -2.2% | -11.8% | -15.6% |
| Aug 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $6.65 | $6.51 | -2.1% | -12.6% | -20.0% | -20.8% | -21.5% | -22.9% |
| Jul 24 | Goldman Sachs | Maintains | Neutral → Neutral | — | $7.89 | $7.84 | -0.6% | -1.4% | -5.8% | -7.0% | -8.4% | -9.5% |
| Jul 21 | Goldman Sachs | Maintains | Neutral → Neutral | — | $7.60 | $7.63 | +0.4% | +3.8% | +2.4% | -2.2% | -3.4% | -4.9% |
| May 15 | Goldman Sachs | Maintains | Neutral → Neutral | — | $6.89 | $6.83 | -0.9% | +4.2% | -8.4% | -10.2% | -12.2% | -5.8% |
| Dec 7 | Goldman Sachs | Downgrade | Buy → Neutral | — | $10.00 | $10.07 | +0.7% | -5.3% | +0.7% | -9.6% | -8.3% | -4.3% |
| Nov 15 | Cowen & Co. | Maintains | Outperform → Outperform | — | $29.57 | $30.36 | +2.7% | -1.8% | -16.9% | -22.6% | -30.6% | -29.7% |
| Aug 18 | BTIG | Maintains | Buy → Buy | — | $44.22 | $44.88 | +1.5% | -3.7% | -11.2% | -14.9% | -16.4% | -11.2% |
| Aug 16 | Jefferies | Downgrade | Buy → Hold | — | $79.20 | $58.08 | -26.7% | -33.3% | -44.2% | -46.2% | -50.4% | -52.5% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 392 | $65.19 | $26K | 34,942 | +3.90% | -37.64% |
| Apr 29, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | 18 | $64.12 | $1K | 93,216 | +3.90% | -37.64% |
| Apr 29, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | 2,154 | $65.20 | $140K | 93,234 | +3.90% | -37.64% |
8-K · 1.01
! Medium
GeneDx Holdings Corp. -- 8-K 1.01: Financing / Debt Agreement
GeneDx Holdings (WGS) secured a $100 million loan agreement, providing capital to support operations and potentially fund growth initiatives or reduce existing debt obligations.
Mar 2
8-K
GeneDx Holdings Corp. -- 8-K Filing
GeneDx reported 2025 fourth-quarter and full-year financial results, showing the rare disease diagnostics company's performance through its genomic sequencing business.
Feb 23
Data updated apr 27, 2026 9:15am
· Source: massive.com